1146. Real-World Experience Highlighting Tocilizumab Use in the Treatment of COVID-19

BACKGROUND: Tocilizumab (TCZ) was approved by the Food and Drug Administration under emergency use authorization for treatment of COVID-19 in patients requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation. Despite multiple clinical tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Maguire, Christina, Terico, Adrienne, Patel, Hinal, Anesi, George L, Degnan, Kathleen, Dutcher, Lauren, Hamilton, Keith W, Meyer, Nuala J, Talati, Naasha J, Saw, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752726/
http://dx.doi.org/10.1093/ofid/ofac492.984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752726/
http://dx.doi.org/10.1093/ofid/ofac492.984

Ejemplares similares